31522 Federal Register / Vol. 61, No. 120 / Thursday, June 20, 1996 / Notices

8Supra. note 5.

cases where the policy is applied. In

this regard, we note that many of the

issues raised in the requests for

rehearing in this proceeding are raised

in the rehearing requests filed in Shell

Gas Pipeline Company.8 Therefore, we

are dismissing the requests for

rehearing, reconsideration or

clarification filed in this proceeding.

By the Commission.

Linwood A. Watson, Jr.,

Acting Secretary.

[FR Doc. 96–15688 Filed 6–19–96; 8:45 am]

BILLING CODE 6717–01–M

ENVIRONMENTAL PROTECTION

AGENCY

[OPP–00434; FRL–5367–7]

Proposed Testing Guidelines; Notice

of Availability and Request for

Comments

AGENCY: Environmental Protection

Agency (EPA).

ACTION: Notice of availability and

request for comments.

SUMMARY: EPA has established a unified

library for test guidelines issued by the

Office of Prevention, Pesticides and

Toxic Substances (OPPTS), and is

announcing the availability of proposed

testing guidelines for Series 870–Health

Effects Test Guidelines. These test

guidelines have been updated and

harmonized, to the extent possible, with

the Organization for Economic

Cooperation and Development (OECD)

guidelines for testing of chemicals, and

other relevant international standards. A

FIFRA Scientific Advisory Panel (SAP)

meeting to review the Series 870 test

guidelines will be scheduled for this

summer. Complete details of this

meeting will be announced in a Federal

Register notice.

DATES: Comments must be received on

or before August 19, 1996.

ADDRESSES: Interested persons are

invited to submit written comments in

triplicate to: By mail: Public Response

and Program Resources Branch, Field

Operations Division (7506C),

Environmental Protection Agency, 401

M St., SW., Washington, DC 20460. In

person: Bring comments to: Rm. 1132,

CM#2, 1921 Jefferson Davis Highway,

Arlington, VA.

Comments and data may also be

submitted electronically by sending

electronic mail (e-mail) to:

guidelines@epamail.epa.gov. Electronic

comments must be submitted as an

ASCII file avoiding the use of special

characters and any form of encryption.

Comments and data will also be

accepted on disks in WordPerfect in 5.1

file format or ASCII file format. All

comments and data in electronic form

must be identified by the docket number

‘‘OPP–00434’’ (FRL–5367–7). No

Confidential Business Information (CBI)

should be submitted through e-mail.

Electronic comments on this document

may be filed online at many Federal

Depository Libraries. Additional

information on electronic submissions

can be found under

‘‘SUPPLEMENTARY INFORMATION.’’

Information submitted as a comment

in response to this notice may be

claimed confidential by marking any

part or all of that information as CBI.

Information so marked will not be

disclosed except in accordance with

procedures set forth in 40 CFR part 2.

A copy of the comment that does not

contain CBI must be submitted for

inclusion in the public docket.

Information not marked confidential

will be included in the public docket

without prior notice. All statements will

be made part of the record.

FOR FURTHER INFORMATION CONTACT: By

mail: Leonard Keifer, Office of Pollution

Prevention and Toxics (7403), U.S.

Environmental Protection Agency, 401

M Street, SW., Washington, DC 20460;

telephone: (202) 260–1548; e-mail:

keifer.leonard@epamail.epa.gov.

By mail: William Sette, Office of

Pesticide Programs (7509C), U.S.

Environmental Protection Agency, 401

M Street, SW., Washington, DC 20460;

telephone: (703) 305–6375; e-mail:

sette.william@epamail.epa.gov.

Copies of documents may be obtained

by contacting: By mail: Public Docket

and Freedom of Information Section,

Field Operations Division (7506C),

Office of Pesticide Programs,

Environmental Protection Agency, 401

M St., SW., Washington, DC 20460. In

person or for courier pick-up: Office

location and telephone number: Rm.

1132, CM #2, 1921 Jefferson Davis

Highway, Arlington, VA, (703) 305–

5805. By internet: e-mail requests to:

guidelines@epamail.epa.gov or via the

EPA Public Access Gopher

(gopher.epa.gov) under the heading

‘‘Environmental Test Methods and

Guidelines.’’

SUPPLEMENTARY INFORMATION: The

Agency is revising its test guidelines for

Series 870—Health Effects Test

Guidelines. Guidelines in the 870 Series

are for use by the Office of Pesticide

Programs (OPP) and the Office of

Pollution Prevention and Toxics (OPPT)

and have been harmonized with those of

OECD. The proposed guidelines are

being made available for comment. All

interested parties are encouraged to

submit comments on the proposed

guidelines. Specific comments should

reference the specific number and

paragraph or subparagraph of the

appropriate proposed guideline.

Recommended technical or scientific

changes/modifications should be

supported by current scientific/

technical knowledge and include

supporting references. References may

be to the published literature, studies

submitted to the Agency in support of

registration, and unpublished data.

Citations must be sufficiently detailed

so as to allow the Agency to obtain

copies of the original documents and

unpublished data supplied to allow

their evaluation.

A record has been established for this

notice under docket number ‘‘OPP–

00434’’ (including comments and data

submitted electronically as described

below). A public version of this record,

including printed, paper versions of

electronic comments, which does not

include any information claimed as CBI,

is available for inspection from 8:00

a.m. to 4:30 p.m., Monday through

Friday, excluding legal holidays. The

public record is located in Rm. 1132 of

the Public Response and Program

Resources Branch, Field Operations

Division (7506C), Office of Pesticide

Programs, Environmental Protection

Agency, Crystal Mall #2, 1921 Jefferson

Davis Highway, Arlington, VA.

Electronic comments can be sent

directly to EPA at:

guidelines@epamail.epa.gov

Electronic comments must be

submitted as an ASCII file avoiding the

use of special characters and any form

of encryption.

The official record for this notice, as

well as the public version, as described

above will be kept in paper form.

Accordingly, EPA will transfer all

comments received electronically into

printed, paper form as they are received

and will place the paper copies in the

official record which will also include

all comments submitted directly in

writing. The official record is the paper

record maintained at the address in

‘‘ADDRESSES’’ at the beginning of this

document.

The following is the complete list of

proposed guidelines being made

available at this time:
Federal Register / Vol. 61, No. 120 / Thursday, June 20, 1996 / Notices 31523

Series 870—Health Effects Test Guidelines

OPPTS

Number Name

Existing Numbers EPA Pub.

no.

OTS OPP OECD 712–C–

Group A—Acute Toxicity Test Guidelines.

870.1000 Acute toxicity testing—background none none none 96–189

870.1100 Acute oral toxicity 798.1175 81–1 401 96–190

870.1200 Acute dermal toxicity 798.1100 81–2 402 96–192

870.1300 Acute inhalation toxicity 798.1150 81–3 403 96–193

870.1350 Acute inhalation toxicity with histopathology none none none 96–291

Group B—Specific Organ/Tissue Toxicity Test Guidelines.

870.2400 Acute eye irritation 798.4500 81–4 405 96–195

870.2500 Acute dermal irritation 798.4470 81–5 404 96–196

870.2600 Skin sensitization 798.4100 81–6 406 96–197

Group C—Subchronic Toxicity Test Guidelines.

870.3100 90-Day oral toxicity 798.2650 82–1 408 96–199

870.3150 Subchronic nonrodent oral toxicity—90-day none 82–1 409 96–200

870.3200 Repeated dose dermal toxicity—21/28 days none 82—2 410 96–201

870.3250 Subchronic dermal toxicity—90 days 798.2250 82–3 411 96–202

870.3465 Subchronic inhalation toxicity 798.2450 82–4 413 96–204

870.3500 Preliminary developmental toxicity screen 798.4420 none none 96–205

870.3600 Inhalation developmental toxicity study 798.4350 none none 96–206

870.3700 Prenatal developmental toxicity study1 798.4900 83–3 414 96–207

870.3800 Reproduction and fertility effects1 798.4700 83–4 416 96–208

Group D—Chronic Toxicity Test Guidelines.

870.4100 Chronic toxicity 798.3260 83–1 452 96–210

870.4200 Carcinogenicity 798.3300 83–2 451 96–211

870.4300 Combined chronic toxicity/carcinogenicity 798.3320 83–5 453 96–212

Group E—Genetic Toxicity Test Guidelines.

870.5100 Escherichia coli WP2 and WP2 uvrA reverse mutation assays 798.5100 84–2 471, 472 96–247

870.5140 Gene mutation in Aspergillus nidulans 798.5140 84–2 none 96–215

870.5195 Mouse biochemical specific locus test 798.5195 84–2 none 96–216

870.5200 Mouse visible specific locus test 798.5200 84–2 none 96–217

870.5250 Gene mutation in Neurospora crassa 798.5250 84–2 none 96–218

870.5265 The Salmonella typhimurium reverse mutation assay 798.5265 84–2 471, 472 96–219

870.5275 Sex-linked recessive lethal test in Drosophila melanogaster 798.5275 84–2 477 96–220

870.5300 Detection of gene mutations in somatic cells in culture 798.5300 84–2 476 96–221

870.5375 In vitro mammalian cytogenetics 798.5375 84–2 473 96–223

870.5380 In vivo mammalian cytogenetics tests: spermatogonial chromosomal aberrations 798.5380 84–2 none 96–224

870.5385 In vivo mammalian cytogenetics tests: Bone marrow chromosomal analysis 798.5385 84–2 475 96–225

870.5395 In vivo mammalian cytogenetics tests: Erythrocyte micronucleus assay 798.5395 84–2 474 96–226

870.5450 Rodent dominant lethal assay 798.5450 84–2 478 96–227

870.5460 Rodent heritable translocation assays 798.5460 84–2 485 96–228

870.5500 Bacterial DNA damage or repair tests 798.5500 84–2 none 96–229

870.5550 Unscheduled DNA synthesis in mammalian cells in culture 798.5550 84–2 482 96–230

870.5575 Mitotic gene conversion in Saccharomyces cerevisiae 798.5575 84–2 481 96–232

870.5900 In vitro sister chromatid exchange assay 798.5900 84–2 479 96–234

870.5915 In vivo sister chromatid exchange assay 798.5915 84–2 none 96–235

Group F—Neurotoxicity Test Guidelines.

870.6100 Delayed neurotoxicity of organophosphorus substances following acute and 28–

day exposure

798.6450,

.6540, .6560

81–7,

82–5,

82–6

418, 419 96–237

870.6200 Neurotoxicity screening battery 798.6050,

.6200, .6400

81–8,

82–7,

83–1

none 96–238

870.6300 Developmental neurotoxicity study none 83–6 none 96–239

870.6500 Schedule-controlled operant behavior 798.6500 85–5 none 96–240

870.6850 Peripheral nerve function 798.6850 85–6 none 96–241

870.6855 Neurophysiology: Sensory evoked potentials 798.6855 none none 96–242

Group G—Special Studies Test Guidelines.
31524 Federal Register / Vol. 61, No. 120 / Thursday, June 20, 1996 / Notices

Series 870—Health Effects Test Guidelines—Continued

OPPTS

Number Name

Existing Numbers EPA Pub.

no.

OTS OPP OECD 712–C–

870.7200 Domestic animal safety none none none 96–349

870.7485 Metabolism and pharmacokinetics2 798.7485 85–1 417 95–244

870.7600 Dermal penetration none 85–3 none 96–350

870.7800 Immunotoxicity none 85–7 none 96–351

Group H—Health Effects Chemical-Specific Test Guidelines.

870.8223 Pharmacokinetic test 795.223 none none 96–250

870.8245 Dermal pharmacokinetics of DGBE and DGBA 795.225 none none 96–251

870.8300 Dermal absorption for compounds that are volatile and metabolized to carbon dioxide795.226 none none 96–252

870.8320 Oral/dermal pharmacokinetics 795.228 none none 96–253

870.8340 Oral and inhalation pharmacokinetic test 795.230 none none 96–254

870.8360 Pharmacokinetics of isopropanol 795.231 none none 96–255

870.8380 Inhalation and dermal pharmacokinetics of commercial hexane 795.232 none none 96–256

870.8500 Toxicokinetic test 795.235 none none 96–257

870.8600 Developmental neurotoxicity screen 795.250 none none 96–258

870.8700 Subchronic oral toxicity test 795.260 none none 96–259

870.8800 Morphologic transformation of cells in culture 795.285 none none 96–260

1Notice of availability published at 61 FR 8282, March 4, 1996.

2Notice of availability published at 60 FR 45158, August 30, 1995.

List of Subjects

Environmental protection, Test

guidelines.

Dated: June 12, 1996.

Lynn R. Goldman,

Assistant Administrator for Prevention,

Pesticides and Toxic Substances.

[FR Doc. 96–15810 Filed 6–19–96; 8:45 am]

BILLING CODE 6560–50–F

FEDERAL COMMUNICATIONS

COMMISSION

[Report No. 2137]

Petitions for Reconsideration and

Clarification of Action in Rulemaking

Proceedings

June 14, 1996.

Petitions for reconsideration and

clarification have been filed in the

Commission’s rulemaking proceeding

listed in this Public Notice and

published pursuant to 47 CFR Section

1.429(e). The full text of these

documents are available for viewing and

copying in Room 239, 1919 M Street,

N.W., Washington, D.C. or may be

purchased from the Commission’s copy

contractor, ITS, Inc. (202) 857–3800.

Oppositions to these petitions must be

filed within 15 days of the date of

public notice of the petitions in the

Federal Register. See § 1.4(b)(1) of the

Commission’s rules (47 CFR 1.4(b)(1)).

Replies to an opposition must be filed

within 10 days after the time for filing

oppositions has expired.

Subject: Amendment of Section

73.202(b), FM Broadcast Stations,

Table of Allotments. (Raleigh, NC).

(MM Docket No. 88–306). Number of

Petition Filed: 1.

Subject: Amendment of Section

73.202(b), FM Broadcast Stations,

Table of Allotments. (Beverly Hills,

Chiefland, Holiday, Micanopy and

Sarasota, FL) (MM Docket No. 92–195,

RM–7091, RM–7146, RM–8123, RM–

8124). Number of Petition Filed: 1.

Subject: Implementation of Sections of

the Cable Television Consumer

Protection and Competition Act of

1992: Rate Regulation (MM Docket

No. 92–266). Leased Commercial

Access (CS Docket No. 96–60).

Number of Petitions Filed: 3.

Subject: Implementation of Section 17

of the Cable Television Consumer

Protection and Competition Act of

1993; Compatibility Between Cable

System and Consumer Electronics

Equipment (ET Docket No. 93–7).

Number of Petitions Filed: 2.

Subject: Amendment of Part 90 of the

Commission’s Rules to Adopt

Regulations for Automatic Vehicle

Monitoring Systems. (PR Docket No.

93–61). Number of Petitions Filed: 3.

Subject: Amendment of Parts 2, 15 and

97 of the Commission’s Rules to

Permit Use of Radio Frequencies

Above 40 GHz for New Radio

Applications. (ET Docket No. 94–124,

RM–8308). Number of Petitions Filed:

2.

Subject: Implementation of Sections

202(f), 202(i) and 301(i) of the

Telecommunications Act of 1996;

Cable Television Antitrafficking,

Network and MMDS/SMATV Crossownership Rules (CS Docket No. 96–

56). Number of Petitions Filed: 2.

Federal Communications Commission.

William F. Caton,

Acting Secretary.

[FR Doc. 96–15672 Filed 6–19–96; 8:45 am]

BILLING CODE 6712–01–M

FEDERAL DEPOSIT INSURANCE

CORPORATION

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Federal Deposit Insurance

Corporation (FDIC).

ACTION: Notice and request for comment.

BACKGROUND: In accordance with the

requirements of the Paperwork

Reduction Act of 1995 (44 U.S.C.

chapter 35), the FDIC may not conduct

or sponsor, and the respondent is not

required to respond to, an information

collection that has been extended,

revised, or implemented on or after

October 1, 1995, unless it displays a

currently valid Office of Management

and Budget (OMB) control number. A

proposed new collection of information

is hereby published for comment. At the

end of the comment period, the

comments and recommendations

received will be analyzed to determine

the extent to which the collection